![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Enrolling by invitation |
Unique ID issued by UMIN | UMIN000040343 |
Receipt No. | R000045916 |
Scientific Title | Impact of Physician-Patient Information on Patient Satisfaction in Determining Treatment Strategies for Patients with Ulcerative Colitis. |
Date of disclosure of the study information | 2020/05/10 |
Last modified on | 2020/11/08 |
Basic information | ||
Public title | Impact of Physician-Patient Information on Patient Satisfaction in Determining Treatment Strategies for Patients with Ulcerative Colitis. | |
Acronym | Impact of Physician-Patient Information on Patient Satisfaction in Determining Treatment Strategies for Patients with Ulcerative Colitis. | |
Scientific Title | Impact of Physician-Patient Information on Patient Satisfaction in Determining Treatment Strategies for Patients with Ulcerative Colitis. | |
Scientific Title:Acronym | Impact of Physician-Patient Information on Patient Satisfaction in Determining Treatment Strategies for Patients with Ulcerative Colitis. | |
Region |
|
Condition | ||
Condition | Ulcerative colitis | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | We conduct a web-based questionnaire survey for patients with ulcerative colitis to clarify the relationship between the amount of information shared by physicians and patients and patient satisfaction with decisions on treatment strategy. Also, to identify the types of information which the patients consider as insufficient. |
Basic objectives2 | Others |
Basic objectives -Others | Patient satisfaction with decisions on treatment strategy |
Trial characteristics_1 | Others |
Trial characteristics_2 | Others |
Developmental phase | Not applicable |
Assessment | |
Primary outcomes | Patient satisfaction with decisions on treatment strategy |
Key secondary outcomes | *Trust in physician scale
*Amount of information by type of information between physicians and patients *Patients characteristics (demographics and clinical characteristics) *Preference for decision-making (Autonomy Preference Index) |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Patients with ulcerative colitis aged over 20 years.
Patients who regularly visit the hospital for the treatment of ulcerative colitis (About once in 3 months). Patients who consented via the web to participate in the present research. |
|||
Key exclusion criteria | No specific criteria | |||
Target sample size | 500 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Toho University Sakura Medical Center | ||||||
Division name | Department of Gastroenterology and Hepatology | ||||||
Zip code | 285-0841 | ||||||
Address | 564-1, Shimoshizu, Sakura City, Chiba | ||||||
TEL | 043-462-8811 | ||||||
matsuoka@fk2.so-net.ne.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | QLife Co., Ltd. | ||||||
Division name | Medical Solution | ||||||
Zip code | 105-0001 | ||||||
Address | 7th Floor, Sumitomo Shin-Toranomon Bldg., 4-3-9 Toranomon, Minato-ku, Tokyo | ||||||
TEL | 03-6860-5020 | ||||||
Homepage URL | |||||||
y-kitahara@qlife.co.jp |
Sponsor | |
Institute | Toho University Sakura Medical Center |
Institute | |
Department |
Funding Source | |
Organization | Mitsubishi Tanabe Pharma Corporation |
Organization | |
Division | |
Category of Funding Organization | Profit organization |
Nationality of Funding Organization | Japan |
Other related organizations | |
Co-sponsor | Mitsubishi Tanabe Pharma Corporation |
Name of secondary funder(s) | Janssen Pharmaceutical K.K. |
IRB Contact (For public release) | |
Organization | Medical corporation Takahashi clinic clinical trial examination committee |
Address | Medical Hat, 1st floor, 1-31, Iwayakitamachi, Nada-ku, Kobe-shi, Hyogo |
Tel | 03-43662-4504 |
no-mori@mebix.co.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Enrolling by invitation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry |
|
||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | N/A |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045916 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |